|
Health economics
Citations 21-30 of 3736 total displayed.
|
Past content
(since Apr 1855):
|
-
- News
- Muscular dystrophy drug looks set for commercial success despite clinical doubts
- Owen Dyer
-
BMJ 2016;355:i5346, doi: 10.1136/bmj.i5346,
-
[Extract]
[Full text]
[PDF]
-
- News
- Clinton promises to expand healthcare access and cut out-of-pocket costs
- Michael McCarthy
-
BMJ 2016;354:i5328, doi: 10.1136/bmj.i5328,
-
[Extract]
[Full text]
[PDF]
-
- News
- CCGs must engage with public on potential service closures, says new guidance
- Gareth Iacobucci
-
BMJ 2016;354:i5297, doi: 10.1136/bmj.i5297,
-
[Extract]
[Full text]
[PDF]
-
- Analysis
- Rethinking primary care’s gatekeeper role
- Geva Greenfield, Kimberley Foley, and Azeem Majeed
-
BMJ 2016;354:i4803, doi: 10.1136/bmj.i4803,
-
[Extract]
[Full text]
[PDF]
-
- Practice
- Clinical assessment and management of multimorbidity: summary of NICE guidance
- Caroline Farmer, Elisabetta Fenu, Norma O’Flynn, and Bruce Guthrie
-
BMJ 2016;354:i4843, doi: 10.1136/bmj.i4843,
-
[Extract]
[Full text]
[PDF]
-
- News
- US hospitals mark up prices more than 20-fold to maximize revenue, study suggests
- Michael McCarthy
-
BMJ 2016;354:i5015, doi: 10.1136/bmj.i5015,
-
[Extract]
[Full text]
[PDF]
-
- News
- US drug industry group launches campaign to defend pricing
- Michael McCarthy
-
BMJ 2016;354:i4902, doi: 10.1136/bmj.i4902,
-
[Extract]
[Full text]
[PDF]
-
- Feature
- PrEP, Truvada, and Gilead
- Andrew Jack
-
BMJ 2016;354:i4800, doi: 10.1136/bmj.i4800,
-
[Extract]
[Full text]
[PDF]
-
- Feature
- Commentary: How to encourage more diagnostics for infectious diseases
- John H Powers
-
BMJ 2016;354:i4744, doi: 10.1136/bmj.i4744,
-
[Extract]
[Full text]
[PDF]
-
- Practice
- Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance
- Jessica Glen, Lefteris Floros, Chris Day, Rachel Pryke on behalf of the Guideline Development Group
-
BMJ 2016;354:i4428, doi: 10.1136/bmj.i4428,
-
[Extract]
[Full text]
[PDF]
|
